Botfet / Company detail
SLS
rejectedSELLAS Life Sciences Group, Inc.
biotech
Moat scoreNot available: not scored quality failout of 100
Rejectionquality_fail
The numbers
Financial metrics
Roic-39.3%
Gross Margin0.0%
Revenue Cagr-86.8%
Fcf Conversion105.7%
Fcf Yield-1.2%
Interest Coverage0.0x
Market Cap B$2.4B
PeNot available: not applicable loss making
Quality PassFail
Founder LedNo
Thesis AlignedYes
Moat QuantNot available: not scored quality fail
Why it may endure
Moat breakdown
Market Share StabilityNot available: not scored quality fail
Network EffectsNot available: not scored quality fail
Pricing PowerNot available: not scored quality fail
Regulatory MoatNot available: not scored quality fail
Switching CostsNot available: not scored quality fail
ConvictionNot available: not scored quality fail
LeadershipNot available: not scored quality fail
VisionNot available: not scored quality fail